MeSH Browser

MeSH Supplementary: Lapuleucel-T
Unique ID: C522647
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C522647
Registry Numbers: 0
Heading Mapped to: *Cancer Vaccines
Frequency: 2
Note: Autologous active cellular immunotherapy with lapuleucel-T was feasible, safe, and well tolerated. The treatment stimulated significant immune responses, which were enhanced after boost infusions
Source: J Clin Oncol 2007 Aug 20;25(24):3680-7
Date of Entry: 2007/09/11
Revision Date: 1955/01/01

Lapuleucel-T MeSH Supplementary Concept Data 2025